Peripheral neuropathies and anti-glycolipid antibodies
The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Abstract
This review charts the progress of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoveries mapping their relationship to subtypes of Guillain-Barré syndrome. Antibodies to >20 different glycolipids have now been associated with a wide range of clinically identifiable acute and chronic neuropathy syndromes. Particular progress has been achieved in understanding the link between acute motor axonal neuropathy and antibodies to GM1, GD1a, GM1b and GalNAc-GD1a, and between the cranial, bulbar and sensory variants of GBS and antibodies to the disialylated gangliosides GQ1b, GT1a, GD1b and GD3. In addition to clinical and serological studies, the origins and measurement of anti-glycolipid antibodies and their relationships to similar carbohydrate structures on infectious organisms, particularly Campylobacter jejuni, are discussed in the context of a molecular mimicry hypothesis. The structure and nomenclature of relevant glycolipids are outlined, along with information on their localization in nerve, and the influence this has on clinical phenotypes. Major advances have been made in animal modelling of anti-glycolipid antibody-associated diseases, both in vitro and in vivo. This has advanced our understanding of the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the motor nerve terminal as a potential site of injury, and led to the creation of rabbit models of anti-GD1b and anti-GM1 antibody-mediated sensory and motor neuropathy, respectively. With such information in place, it will now be possible to determine the precise mechanisms by which antibodies injure the different compartments of peripheral nerve and establish how a range of immunomodulating therapies, including current treatments, exert their therapeutic effects. Despite these very significant advances, considerable gaps in our knowledge persist, and it is likely that other pathogenic pathways operate in inflammatory neuropathy that are unrelated to glycolipid antibodies, although these are outside the scope of this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complementfi xing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990 -991).”
From Biological roles of glycans (2017) · cites this paper as [990]
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Fisher, M. (1956) · New England Journal of Medicine · doi:10.1056/nejm195607122550201 · Cited by 1,069
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study
Jacobs, B. C., Rothbarth, P. H., van der Meché, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., & van Doorn, P. A. (1998) · Neurology · doi:10.1212/wnl.51.4.1110 · Cited by 826
Defining criteria for autoimmune diseases (Witebsky's postulates revisited)
Rose, N. R., & Bona, C. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90244-f · Cited by 814
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS
ASBURY, A. K., ARNASON, B. G., & ADAMS, R. D. (1969) · Medicine · doi:10.1097/00005792-196905000-00001 · Cited by 723
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1993) · Neurology · doi:10.1212/wnl.43.10.1911 · Cited by 705
[10] Gangliosides: Structure, isolation, and analysis
Ledeen, R. W., & Yu, R. K. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)83012-7 · Cited by 701
Cited by
Items 501–600 of 764
Expanding the concept of inflammatory neuropathies
Koike, H., & Sobue, G. (2010) · Brain · doi:10.1093/brain/awq266 · Cited by 5
Glycan Arrays: Construction, Detection, and Analysis
Butler, D. L., Temme, J. S., & Gildersleeve, J. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00061-4 · Cited by 5
Chen, L., Zhang, Y., Qin, N., Han, R., & Li, Y. (2023) · Journal of International Medical Research · doi:10.1177/03000605231193575 · Cited by 5
Anti‐GM1 antibodies: the cause of otherwise unexplained ophthalmoplegias?
Kowal, L. M., Gajus, M. A., & Kornberg, A. J. (2004) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2004.00847.x · Cited by 5
Reisin, R. C., Salutto, V., Aguirre, F., Alvarez, V., Barroso, F. A., Bendersky, M., Berardo, A., Bettini, M., Borrelli, M. M., Chaves, M., et al. (2020) · Neurología Argentina · doi:10.1016/j.neuarg.2020.01.004 · Cited by 5
Miljković-Selimović, B., Ng, L.-K., Price, L. J., Kocić, B. D., & Babić, T. (2010) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1012721m · Cited by 5
Beleidy, A. E., Khattab, A. A. E.-H., El-Sherbini, S. A., El-Adely, T. Z., Sleem, H. M., & Hawary, R. E. (2013) · Pediatria Polska · doi:10.1016/j.pepo.2013.02.006 · Cited by 5
van Schaik, I. N., Bouché, P., Illa, I., Léger, J., den Bergh, P. Y. K. V., Cornblath, D. R., Evers, E., Hadden, R. D. M., Hughes, R. A., Koski, C. L., et al. (2006) · Wiley eBooks · doi:10.1002/9780470753279.ch24 · Cited by 5
Guillain-Barré Syndrome and Campylobacter jejuni Infection: A Review
Mawla, N. N., Sultana, S., & Akhter, N. (2014) · Delta Medical College Journal · doi:10.3329/dmcj.v2i1.17794 · Cited by 5
Autoantibodies in neuromuscular autoimmune disorders
Lang, B., & Willcox, N. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.2.293 · Cited by 5
Tishler, M., & Shoenfeld, Y. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50027-5 · Cited by 5
Islam, Z. (2010) · RePub (Erasmus University Rotterdam) · Cited by 5
Boyadjiev, I., Léone, M., Garnier, F., Thomachot, L., & Martin, C. (2005) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2005.06.002 · Cited by 5
Fujii, K., Shiohama, T., Uchida, T., Ikehara, H., Fukuhara, T., Sawada, D., Aoyama, H., Uchikawa, H., Yoshii, S., Arahata, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3821485 · Cited by 5
Sarkar, A., Nagappa, M., Dey, S., Mondal, S., Babu, G. S., Choudhury, S. P., Akhil, P., & Debnath, M. (2023) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12605 · Cited by 5
Treatment of Multifocal Motor Neuropathy with Intravenous Immunoglobulin
Koski, C. L. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0016-5 · Cited by 4
M, H. E. A. (2015) · International Journal of Neurorehabilitation · doi:10.4172/2376-0281.1000159 · Cited by 4
Clinical Differential Diagnosis of Multifocal Motor Neuropathy
Léger, J., Gavriliuc, E., & Professor (2012) · European Neurological Review · doi:10.17925/enr.2012.07.02.124 · Cited by 4
The Study Progress of B Cells and Neuroimmunological Diseases
Karim, M. R., & Wang, Y. F. (2016) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000369 · Cited by 4
Unclassified subtype of Guillain-Barré syndrome is associated with quick recovery
Ohnari, K., Okada, K., Mafune, K., Kusunoki, S., & Adachi, H. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.07.025 · Cited by 4
Hotta, S., Nagaoka, T., Taguchi, K., Nakatani, Y., Utsnomiya, I., Masuda, Y., Abe, K., & Yuki, N. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1480-z · Cited by 4
Rodríguez, A. M., Antón, J. M., Castaín, M. J. N., & Ramos‐Fernández, J. M. (2012) · Neurología · doi:10.1016/j.nrl.2011.04.001 · Cited by 4
Infection and Guillain-Barré syndrome
van Sorge, N. M., van den Berg, L. H., Jansen, M. D., van de Winkel, J. G. J., & van der Pol, W. L. (2004) · Elsevier eBooks · doi:10.1016/b978-044451271-0.50046-6 · Cited by 4
A reinterpretation of certain disorders affecting the eye muscles and their tissues.
Poonyathalang, A., Khanna, S., & Leigh, R. J. (2007) · PubMed Central · Cited by 4
Clinical and Diagnostic Role of Ganglioside Antibody Testing.
Gorenjac, M. (2004) · PubMed Central · Cited by 4
Myelin: Molecular Architecture of CNS and PNS Myelin Sheath
Scherer, S. S., & Arroyo, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.01019-6 · Cited by 4
Anti-GT1a IgG Antibodies in a Child With Severe Guillain-Barré Syndrome
Schessl, J., Funakoshi, K., Susuki, K., Gold, R., & Korinthenberg, R. (2006) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2006.03.007 · Cited by 4
Acute motor conduction block neuropathy: Another Guillain-Barré syndrome variant
Berciano, J., & García, A. (2004) · Neurology · doi:10.1212/wnl.62.6.1026-a · Cited by 4
Lunn, M. P., Lehmann, H. C., & Sheikh, K. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00079-5 · Cited by 4
Chronic Immune-Mediated Polyneuropathies
Cox, S. Z., & Gwathmey, K. G. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.01.006 · Cited by 3
Intravenous immunoglobulin use in neurology
Keller, C. W., Dalakas, M. C., & Lünemann, J. D. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90887-0.00006-7 · Cited by 3
Kuwahara, M., & Kusunoki, S. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12452 · Cited by 3
Osório, L., Parra, B., Moyano, M., López-González, R., Jimenez-Arango, J. A., Vargas-Manotas, J., Lizarazo, J., Burbano, G. E. R., Llanos, M. D., Rosso, F., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012898 · Cited by 3
Self-citationUse of Antibody Testing in Nervous System Disorders
Willison, H. J., Gilhus, N. E., Graus, F., Jacobs, B. C., Liblau, R., Vedeler, C. A., & Vincent, A. C. (2010) · Wiley eBooks · doi:10.1002/9781444328394.ch6 · Cited by 3
Self-citationIndications actuelles des immunoglobulines polyvalentes
Magy, L. (2012) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31880-1 · Cited by 3
High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy
Nobile‐Orazio, E., Cocito, D., Briani, C., Plasmati, R., Schenone, A. E., Gallia, F., Marjanovic, I., & Suffredini, A. L. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2826-8 · Cited by 3
Immune-mediated ophthalmoparesis with anti-GD1a antibodies
McKean, N., & Chircop, C. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-244273 · Cited by 3
Moody, S., Wanchoo, R. J., Kalamangalam, G. P., Infante, E., & Sheikh, K. A. (2013) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0b013e3182852542 · Cited by 3
Anti-sulfatide reactivity in patients with celiac disease
Saccomanno, D., Tomba, C., Magri, F., Backelandt, P., Roncoroni, L., Doneda, L., Bardella, M. T., Comi, G. P., Bresolin, N., Conte, D., et al. (2016) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2016.1263679 · Cited by 3
Acute unilateral isolated abducens nerve palsy associated with anti-GM1 immunoglobulin M antibody
Son, H., Kim, A., Hong, S. B., & Koo, D. L. (2019) · Annals of Clinical Neurophysiology · doi:10.14253/acn.2019.21.2.105 · Cited by 3
Lardone, R. D., Irazoqui, F. J., & Nores, G. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70063-5 · Cited by 3
Dinutuximab beta‐related severe neurotoxicity: Resolution with the use of plasmapheresis
Papadakis, V., Kelaïdi, C., Zisaki, K., Antoniadi, K., Pitsoulakis, G., & Polychronopoulou, S. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29465 · Cited by 3
Sharma, A., Negi, G., Chaudhary, M., & Parveen, N. (2023) · Langmuir · doi:10.1021/acs.langmuir.3c01301 · Cited by 3
Convolution Neural Network and EVO Based Efficient Method for Detecting Nerve Disorders
Sowparnika, B., Ganu, L., Rai, M., Kaliappan, S., Maranan, R., & Jayalakshmi, V. (2023) · International Conference on Augmented Intelligence and Sustainable Systems (ICAISS) · doi:10.1109/icaiss58487.2023.10250521 · Cited by 3
Yamada, M. H., Ueda, M., Tsuji, S., & Kusunoki, S. (2012) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12002 · Cited by 3
Subacute motor axonal neuropathy associated with the IgG anti-GalNAc-GD1a antibody: Figure 1
Goto, H., Fukudome, T., Kusunoki, S., & Matsuo, H. (2011) · BMJ Case Reports · doi:10.1136/bcr.11.2010.3507 · Cited by 3
Mimetismo molecular en la neuropatogénesis del síndrome de Guillain-Barré
Ortega-Martínez, M., Jaramillo‐Rangel, G., Áncer‐Rodríguez, J., & Trujillo, J. (2005) · Cited by 3
Ivić-Kolevska, S., Miljković-Selimović, B., Kocić, B., & Kolevski, G. (2015) · Journal of Hygienic Engineering and Design · Cited by 3
Guillain-Barré Syndrome With Antibody to Ganglioside GT1a
Yang, T. I., Park, Y. E., Kim, J. K., Yi, S. Y., Kim, T. H., & Kim, D. S. (2010) · Journal of the Korean Neurological Association · Cited by 3
Autoantibodies in Guillain-Barré Syndrome (GBS)
Kaida, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-55594-0_10 · Cited by 3
AUTOINMUNIDAD NEUROLÓGICA EN LOS TIEMPOS DEL ZIKA
Acosta‐Ampudia, Y., Monsalve, D. M., Rodríguez, Y., Albarracin, M. L. G., Ramírez-Santana, C., González-Bravo, D. C., Rodríguez‐Jiménez, M., Rojas‐Villarraga, A., Chaparro, P., & Anaya, J. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Immunneuropathien — Aktuelle Aspekte der Diagnostik und Therapie
Gold, R., Bayas, A., & Toyka, K. V. (2005) · Der Nervenarzt · doi:10.1007/s00115-005-1942-5 · Cited by 3
Polyneuropathies and Antibodies to Nerve Components
Pestronk, A., & Lopate, G. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50100-9 · Cited by 3
Townson, K. H., Speak, A. O., Greenshields, K. N., Goodyear, C. S., Willison, H. J., & Platt, F. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.033 · Cited by 3
Self-citationTetala, K. K. R., Heikema, A. P., Pukin, A. V., Weijers, C. A. G. M., Tio‐Gillen, A. P., Gilbert, M., Endtz, H. P., van Belkum, A., Zuilhof, H. T., Visser, G. M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101594s · Cited by 3
Akıncı, G., Polat, M., Tosun, A. F., Serdaroğlu, G., Gökben, S., & Tekgül, H. (2007) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2007.2521 · Cited by 3
Willison, H. J. (2007) · Elsevier eBooks · doi:10.1016/b978-044452763-9/50079-2 · Cited by 3
Self-citationAutoimmune peripheral neuropathies
Dalakas, M. C. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3691-1.00080-5 · Cited by 3
Sialic Acid-Binding Ig-Like Lectins (Siglecs)
Kim, C. (2022) · Springer eBooks · doi:10.1007/978-981-16-9081-5_7 · Cited by 3
Jacob-Lebas, M., & Vignal‐Clermont, C. (2011) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(11)72111-x · Cited by 3
Ojha, R., & Nepal, G. (2024) · Springer eBooks · doi:10.1007/978-981-99-8676-7_20 · Cited by 3
Parrot proventricular dilatation disease: a possible model of Guillain-Barré syndrome?Preprint
Rossi, G., Crosta, L., & Pesaro, S. (2008) · Nature Precedings · doi:10.1038/npre.2008.2590.1 · Cited by 3
Svensson, S. L. (2013) · cIRcle (University of British Columbia) · doi:10.14288/1.0073017 · Cited by 3
Chaudhuri, A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68175-0 · Cited by 3
Antiganglioside antibodies-Their pathophysiological effects on Guillain-Barre Syndrome and variants-
Kaida, K.-I., & Kusunoki, S. (2011) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.34.29 · Cited by 2
Miller-Fisher syndrome subtype with isolated bilateral mydriasis: a pediatric case report
Yang, F., Tian, Z., Lu, Y., Li, Y., & Liu, K. (2025) · BMC Neurology · doi:10.1186/s12883-025-04180-x · Cited by 2
Guillain–Barré syndrome and albuminocytological dissociation: a narrative review
Muskan, L., Rajab, A., Rasheed, S., Memon, F., Khalid, A., Umar, M., Laique, M., Laique, F., & Giri, B. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000004109 · Cited by 2
Immunotherapies on Guillain–Barré syndrome and other acute autoimmune neuropathies
Luijten, L. W. G., & Jacobs, B. C. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90887-0.00007-9 · Cited by 2
Nakasako, J., Yaguchi, R., Terayama, A., Kuwahara, M., & Nishimoto, Y. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.126039 · Cited by 2
Improve Markers of Oxidative Stress and Coagulation Parameters in Response to Atorvastatin Therapy
Mohammad, B. I. (2014) · Journal of Pharmaceutical Research International · doi:10.9734/bjpr/2014/10140 · Cited by 2
Guzmán, G. E., Lizcano, F., & Marcela Peralta, F. (2015) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2015.02.004 · Cited by 2
A case report of Fisher syndrome with the detection of anti-GM3 and anti-GD1b IgG antibodies
Matsuzono, K., Ozawa, T., Yoshikawa, K., Kusunoki, S., & Fujimoto, S. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3655-0 · Cited by 2
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
den Bergh, P. Y. K. V., Hadden, R. D. M., Bouché, P., Cornblath, D. R., Hahn, A., Illa, I., Koski, C. L., Léger, J., Nobile‐Orazio, E., Pollard, J., et al. (2010) · Wiley eBooks · doi:10.1002/9781444328394.ch20 · Cited by 2
Role of Fcγ Receptor Mediated Inflammation in Immune Neuropathies
Zhang, G., & Sheikh, K. A. (2017) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000490 · Cited by 2
Guillian-Barre syndrome and variants: Antiganglioside antibodies
Murthy, J. M. K. (2017) · Neurology India · doi:10.4103/neuroindia.ni_738_17 · Cited by 2
Shala, A., Panovska, A. P., Brezovska, K., Beretta, G., Šuturkova, L., & Apostolski, S. (2015) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2015.61.01.008 · Cited by 2
High-resolution mapping identifies HLA class II associations with multifocal motor neuropathy
Bos, J. W., Otten, H. G., Herraets, I. J. T., Goedee, H. S., Cats, E. A., de Hoop, T. A., Verduijn, W., van der Pol, W. L., & van den Berg, L. H. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.014 · Cited by 2
Myelin: Molecular Architecture of CNS and PNS Myelin Sheath☆
Scherer, S. S., & Arroyo, E. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04676-6 · Cited by 2
EARLY PREDICTORS OF SEVERE DISABILITY IN GUILLAIN–BARRÉ SYNDROME
Görgülü, Ü., GEÇER, B., Bilen, Ş., & Kolcu, G. (2022) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.1188650 · Cited by 2
Gómez‐Dabó, L., Llauradó, A., Sánchez‐Tejerina, D., González, V., Montalvo-Olmedo, C., Lazaro-Hernandez, C., Rodrigo‐Gisbert, M., López‐Maza, S., Achutegui, M. I., Giramé-Rizzo, L., et al. (2025) · Revista de Neurología · doi:10.31083/rn37744 · Cited by 2
Differenzialdiagnose von Erkrankungen des Plexus brachialis
Ritter, C., Wunderlich, G., Macht, S., Schroeter, M., Fink, G. R., & Lehmann, H. C. (2013) · Der Nervenarzt · doi:10.1007/s00115-013-3949-7 · Cited by 2
Chapter 5 Mechanisms of Symptom Production
Smith, K. J., & McDonald, W. I. (2003) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70034-0 · Cited by 2
Recent Advances in the Treatment of Neurological Autoimmune Disorders
Jagat, R., Sriramoju, B., & Rupinder, K. (2011) · InTech eBooks · doi:10.5772/20681 · Cited by 2
Sensitive detection of hydrophobic antigens using a novel lipid-aggregate based ELISA
Ketelsen, A., & Eriksson, H. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.09.012 · Cited by 2
Yu, R. K., Usuki, S., & Ariga, T. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0870-3_14 · Cited by 2
Multifocal motor neuropathy: and then, 20 years later IVIg therapy
Lievens, I., & Léger, M. (2007) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2007.01827 · Cited by 2
Nagaoka, S. H. T. (2015) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000275 · Cited by 2
Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome
Li, H. (2004) · Neurology · doi:10.1212/wnl.63.10.1985 · Cited by 2
Demyelinating polyneuropathy after long‐term treatment with infliximab
Nakamura, K., Hamaguchi, T., & Yamada, M. (2015) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12642 · Cited by 2
Diagnostic spectrum of multifocal motor neuropathy
Matsui, N., Miyashiro, A., Shimatani, Y., Nodera, H., Izumi, Y., Kuwabara, S., Baba, M., Komori, T., Sonoo, M., Mezaki, T., et al. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12025 · Cited by 2
Katchanov, J., Lünemann, J. D., Masuhr, F., Meisel, A., M�ller, H., & Zschenderlein, R. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0538-5 · Cited by 2
IgG anti‐Galnac‐GD1a antibodies bind to neuromuscular junctions of rat hemidiaphragm
Nagaoka, T., Hotta, S., Chiba, T., Utsunomiya, I., Abe, K., Yoshino, H., Koshikawa, C., & Taguchi, K. (2012) · Muscle & Nerve · doi:10.1002/mus.23385 · Cited by 2
Virologic Evidences of Active Herpesviridae Infection in Children With Guillain-Barre Syndrome
Armin, S., Shamsabadi, F. M., Kiomarci, A., & Jadali, F. (2013) · Archives of Pediatric Infectious Diseases · doi:10.5812/pedinfect.11251 · Cited by 2
New and emerging treatments of Guillain–Barré syndrome
Lehmann, H. C., Zhang, G., & Sheikh, K. A. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.925393 · Cited by 2
Autoantibodies in Neuromuscular Disorders
Querol, L., Gallardo, E., & Illa, I. (2016) · Springer eBooks · doi:10.1007/978-3-319-29514-5_1 · Cited by 2
Lunn, M. P., & Sheikh, K. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00053-8 · Cited by 2
Treatment and Management of Autoimmune Neuropathies
El-Abassi, R. N., Soliman, M. Y., Levy, M. H., & England, J. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-71317-7.00015-9 · Cited by 2
Mihajkoska, E., Panovska, A. P., Brezovska, K., Pendovska, M., Taravari, A., & Šuturkova, L. (2021) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2021.67.01.001 · Cited by 2
Gold, R., Müllges, W., Hansen, H.-C., Anetseder, M., Metterlein, T., Müller, R., Hund, E., Winterholler, M., & Toyka, K. V. (2008) · Springer eBooks · doi:10.1007/978-3-540-68317-9_40 · Cited by 2
Metadata
- Authors
- Willison, H. J.
- Affiliations
- Southern General Hospital (GB)
- Corresponding author
- Willison, H. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 125
- Issue
- 12
- Pages
- 2591-2625
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2021949020
- Cited by
- 710
- References
- 286
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 12 · 2018: 20 · 2017: 23 · 2016: 34 · 2015: 30 · 2014: 37 · 2013: 32 · 2012: 33
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- anti-glycolipid antibodies, peripheral neuropathy, Guillain-Barré syndrome, Miller Fisher syndrome, acute motor axonal neuropathy, gangliosides, GM1, GD1a, GQ1b, Campylobacter jejuni, molecular mimicry, sensory neuropathy, immunomodulatory therapy
- MeSH terms
- Animals, Autoantibodies, Glycolipids, Humans, Immunoglobulin G, Immunoglobulin M, Peripheral Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.